TITLE

The pulmonary physician in critical care • Illustrative case 2: Interstitial lung disease

AUTHOR(S)
Jones, A.T.; du Bois, R.M.; Wells, A.U.
PUB. DATE
April 2003
SOURCE
Thorax;Apr2003, Vol. 58 Issue 4, p361
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Describes the case history of a patient admitted to a hospital's intensive care unit with interstitial lung disease deteriorating to respiratory failure. Use of diagnostic techniques; Role of lung transplantation.
ACCESSION #
10082571

 

Related Articles

  • Editor's Commentary.  // Respiratory Care;Apr2010, Vol. 55 Issue 4, p377 

    The article discusses various reports published within the issue, including one by Gael Bourdin and colleagues on early mobilization of patients in intensive care unit, one by Oriol Roca and colleagues on the effectiveness of high-flow oxygen therapy during acute respiratory failure, and one by...

  • Metastatic Prostate Cancer Presenting as Interstitial Lung Disease. Gupta, Shweta; Ukoha, Ozuru; Sahni, Ashima; Hollowell, Courtney M. P.; Sekosan, Marin // Scripta Medica;2012, Vol. 43 Issue 2, p116 

    Prostate cancer can metastasize to the lungs, but mostly in the form of pulmonary nodules and rarely as lymphangitic carcinomatosis. Also it is rare to have metastatic prostate cancer with no prostatic symptoms at diagnosis. We describe a rare case where a middle aged man presented with isolated...

  • Editorial Comment: To match or not to match: the fruit-basket puzzle. Brunelli, Alessandro // European Journal of Cardio-Thoracic Surgery;Jan2013, Vol. 43 Issue 1, pe24 

    The author reflects on the study of L. Voltolini and colleagues regarding interstitial lung disease (ILD's) effects on the results of patients referred to pulmonary resection for lung cancer. He states that ILD patients has a higher incidence of postoperative respiratory complications and the...

  • Interstitial lung disease and anti-Jo-i antibodies: difference between acute and gradual onset. Tillie-Leblond, I.; Wisiez, M.; Valeyre, B.; Crestani, B.; Rabbat, A.; Israel-Biet, D.; Humbert, M.; Couderc, L. J.; Wallaert, B.; Cadranel, J. // Thorax;Jan2008, Vol. 63 Issue 1, p53 

    Aim: A multicentre retrospective study was undertaken to examine patients with interstitial lung disease (ILD) with the initial clinical manifestation of an anti-synthetase syndrome (anti-Jo-1 antibodies), and to analyse the characteristics and long-term outcome of these patients according to...

  • Noninvasive mechanical ventilation: An 18-month experience of two tertiary care hospitals in north India. Verma, Ajay K.; Mishra, Mayank; Kant, Surya; Kumar, Anand; Verma, Sushil K.; Chaudhri, Sudhir; Prabhuram, J. // Lung India; 

    Background: Noninvasive mechanical ventilation (NIMV) is the delivery of positive pressure ventilation through an interface to upper airways without using the invasive airway. Use of NIMV is becoming common with the increasing recognition of its benefits. Objectives: This study was done to...

  • Idiopathic Pulmonary Fibrosis: Evolving Concepts. Ryu, Jay H.; Moua, Teng; Daniels, Craig E.; Hartman, Thomas E.; Yi, Eunhee S.; Utz, James P.; Limper, Andrew H. // Mayo Clinic Proceedings;Aug2014, Vol. 89 Issue 8, p1130 

    Idiopathic pulmonary fibrosis (IPF) occurs predominantly in middle-aged and older adults and accounts for 20% to 30% of interstitial lung diseases. It is usually progressive, resulting in respiratory failure and death. Diagnostic criteria for IPF have evolved over the years, and IPF is currently...

  • Interstitial lung disease associated with drug therapy. Camus, P.; Kudoh, S.; Ebina, M. // British Journal of Cancer;8/1/2004 Supplement, Vol. 91, pS18 

    Drug-associated interstitial lung disease (ILD) is not uncommon, with diverse patterns ranging from benign infiltrates to the potentially fatal acute respiratory distress syndrome. As acute respiratory failure due to drug-associated ILD has an unpredictable onset and rapid time course,...

  • Erlotinib.  // Reactions Weekly;10/6/2007, Issue 1172, p15 

    The article describes the case of a 60-year-old male patient who developed interstitial lung disease leading to respiratory failure while receiving erlotinib for non-small cell lung cancer. The patient used to be a smoker. The patient subsequently died after several weeks' intensive care. He was...

  • Rituximab.  // Reactions Weekly;9/26/2009, Issue 1271, p29 

    The article describes the case of an older man who developed acute interstitial lung disease after receiving rituximab for chronic antibody-mediated kidney allograft rejection. The patient experienced progressive respiratory failure and became oxygen dependent. The man was given steroids to...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics